Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Same-day antimicrobial susceptibility test using acoustic-enhanced flow cytometry visualized with supervised machine learning.

Inglis TJJ, Paton TF, Kopczyk MK, Mulroney KT, Carson CF.

J Med Microbiol. 2019 Oct 30. doi: 10.1099/jmm.0.001092. [Epub ahead of print]

PMID:
31665100
2.

Air sampling to assess potential generation of aerosolized viable bacteria during flow cytometric analysis of unfixed bacterial suspensions.

Carson CF, Inglis TJ.

Version 2. Gates Open Res. 2018 Feb 27 [revised 2018 Jan 1];1:2. doi: 10.12688/gatesopenres.12759.2. eCollection 2017.

3.

Human pleural fluid is a potent growth medium for Streptococcus pneumoniae.

Popowicz ND, Lansley SM, Cheah HM, Kay ID, Carson CF, Waterer GW, Paton JC, Brown JS, Lee YCG.

PLoS One. 2017 Nov 30;12(11):e0188833. doi: 10.1371/journal.pone.0188833. eCollection 2017.

4.

Analysis of early mesothelial cell responses to Staphylococcus epidermidis isolated from patients with peritoneal dialysis-associated peritonitis.

McGuire AL, Mulroney KT, Carson CF, Ram R, Morahan G, Chakera A.

PLoS One. 2017 May 24;12(5):e0178151. doi: 10.1371/journal.pone.0178151. eCollection 2017.

5.

In vitro data support the investigation of vinegar as an antimicrobial agent for PD-associated Pseudomonas exit site infections.

Carson CF, Ash O, Chakera A.

Nephrology (Carlton). 2017 Feb;22(2):179-181. doi: 10.1111/nep.12848.

PMID:
28064452
6.

Therapeutic Potential of Tea Tree Oil for Scabies.

Thomas J, Carson CF, Peterson GM, Walton SF, Hammer KA, Naunton M, Davey RC, Spelman T, Dettwiller P, Kyle G, Cooper GM, Baby KE.

Am J Trop Med Hyg. 2016 Feb;94(2):258-266. doi: 10.4269/ajtmh.14-0515. Epub 2016 Jan 19. Review.

7.
8.

Scabies: an ancient global disease with a need for new therapies.

Thomas J, Peterson GM, Walton SF, Carson CF, Naunton M, Baby KE.

BMC Infect Dis. 2015 Jul 1;15:250. doi: 10.1186/s12879-015-0983-z.

9.

Lack of evidence that essential oils affect puberty.

Carson CF, Tisserand R, Larkman T.

Reprod Toxicol. 2014 Apr;44:50-1. doi: 10.1016/j.reprotox.2013.09.010. Epub 2014 Feb 17. No abstract available.

PMID:
24556344
10.

Effect of habituation to tea tree (Melaleuca alternifolia) oil on the subsequent susceptibility of Staphylococcus spp. to antimicrobials, triclosan, tea tree oil, terpinen-4-ol and carvacrol.

Thomsen NA, Hammer KA, Riley TV, Van Belkum A, Carson CF.

Int J Antimicrob Agents. 2013 Apr;41(4):343-51. doi: 10.1016/j.ijantimicag.2012.12.011. Epub 2013 Mar 6.

PMID:
23481659
11.

Candida albicans adhesion to human epithelial cells and polystyrene and formation of biofilm is reduced by sub-inhibitory Melaleuca alternifolia (tea tree) essential oil.

Sudjana AN, Carson CF, Carson KC, Riley TV, Hammer KA.

Med Mycol. 2012 Nov;50(8):863-70. doi: 10.3109/13693786.2012.683540. Epub 2012 May 15.

PMID:
22587732
12.

[The side effects are exaggerated].

Carson CF, Hammer KA, Southwell IA, Riley TV.

Lakartidningen. 2012;109(32-33):1419. Swedish. No abstract available.

PMID:
23909012
13.
14.

Survey of the antimicrobial activity of commercially available Australian tea tree (Melaleuca alternifolia) essential oil products in vitro.

Thomsen PS, Jensen TM, Hammer KA, Carson CF, Mølgaard P, Riley TV.

J Altern Complement Med. 2011 Sep;17(9):835-41. doi: 10.1089/acm.2010.0508. Epub 2011 Aug 19.

PMID:
21854197
15.

Uncontrolled, open-label, pilot study of tea tree (Melaleuca alternifolia) oil solution in the decolonisation of methicillin-resistant Staphylococcus aureus positive wounds and its influence on wound healing.

Edmondson M, Newall N, Carville K, Smith J, Riley TV, Carson CF.

Int Wound J. 2011 Aug;8(4):375-84. doi: 10.1111/j.1742-481X.2011.00801.x. Epub 2011 May 12.

PMID:
21564552
16.

Inhibition of established subcutaneous murine tumour growth with topical Melaleuca alternifolia (tea tree) oil.

Greay SJ, Ireland DJ, Kissick HT, Heenan PJ, Carson CF, Riley TV, Beilharz MW.

Cancer Chemother Pharmacol. 2010 Nov;66(6):1095-102. doi: 10.1007/s00280-010-1267-3. Epub 2010 Feb 21.

PMID:
20577741
17.

Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol.

Greay SJ, Ireland DJ, Kissick HT, Levy A, Beilharz MW, Riley TV, Carson CF.

Cancer Chemother Pharmacol. 2010 Apr;65(5):877-88. doi: 10.1007/s00280-009-1093-7. Epub 2009 Aug 13.

PMID:
19680653
18.

Antimicrobial and anti-inflammatory activity of five Taxandria fragrans oils in vitro.

Hammer KA, Carson CF, Dunstan JA, Hale J, Lehmann H, Robinson CJ, Prescott SL, Riley TV.

Microbiol Immunol. 2008 Nov;52(11):522-30. doi: 10.1111/j.1348-0421.2008.00070.x.

19.

Diagnosis of Helicobacter pylori infection in a high-prevalence pediatric population: a comparison of 2 fecal antigen testing methods and serology.

Cherian S, Burgner DP, Carson CF, Sanfilippo FM, Cook AG, Forbes DA.

J Pediatr Gastroenterol Nutr. 2008 Aug;47(2):130-5. doi: 10.1097/MPG.0b013e31815bc5b3.

PMID:
18664862
20.

Frequencies of resistance to Melaleuca alternifolia (tea tree) oil and rifampicin in Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.

Hammer KA, Carson CF, Riley TV.

Int J Antimicrob Agents. 2008 Aug;32(2):170-3. doi: 10.1016/j.ijantimicag.2008.03.013. Epub 2008 Jun 20.

PMID:
18571379
21.

Role of the MexAB-OprM efflux pump of Pseudomonas aeruginosa in tolerance to tea tree (Melaleuca alternifolia) oil and its monoterpene components terpinen-4-ol, 1,8-cineole, and alpha-terpineol.

Papadopoulos CJ, Carson CF, Chang BJ, Riley TV.

Appl Environ Microbiol. 2008 Mar;74(6):1932-5. doi: 10.1128/AEM.02334-07. Epub 2008 Jan 11.

22.

Use of deception to achieve double-blinding in a clinical trial of Melaleuca alternifolia (tea tree) oil for the treatment of recurrent herpes labialis.

Carson CF, Smith DW, Lampacher GJ, Riley TV.

Contemp Clin Trials. 2008 Jan;29(1):9-12. Epub 2007 May 6.

PMID:
17544340
23.

Susceptibility of pseudomonads to Melaleuca alternifolia (tea tree) oil and components.

Papadopoulos CJ, Carson CF, Hammer KA, Riley TV.

J Antimicrob Chemother. 2006 Aug;58(2):449-51. Epub 2006 May 30.

PMID:
16735435
24.

Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties.

Carson CF, Hammer KA, Riley TV.

Clin Microbiol Rev. 2006 Jan;19(1):50-62. Review.

25.

A review of the toxicity of Melaleuca alternifolia (tea tree) oil.

Hammer KA, Carson CF, Riley TV, Nielsen JB.

Food Chem Toxicol. 2006 May;44(5):616-25. Epub 2005 Oct 21. Review.

PMID:
16243420
26.
27.

Assessment of the antibacterial activity of tea tree oil using the European EN 1276 and EN 12054 standard suspension tests.

Messager S, Hammer KA, Carson CF, Riley TV.

J Hosp Infect. 2005 Feb;59(2):113-25.

PMID:
15620445
28.

Tolerance of Pseudomonas aeruginosa to Melaleuca alternifolia (tea tree) oil is associated with the outer membrane and energy-dependent cellular processes.

Longbottom CJ, Carson CF, Hammer KA, Mee BJ, Riley TV.

J Antimicrob Chemother. 2004 Aug;54(2):386-92. Epub 2004 Jul 14.

PMID:
15254026
29.

Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae.

Hammer KA, Carson CF, Riley TV.

J Antimicrob Chemother. 2004 Jun;53(6):1081-5. Epub 2004 May 12.

PMID:
15140856
30.

Susceptibility of oral bacteria to Melaleuca alternifolia (tea tree) oil in vitro.

Hammer KA, Dry L, Johnson M, Michalak EM, Carson CF, Riley TV.

Oral Microbiol Immunol. 2003 Dec;18(6):389-92.

PMID:
14622345
31.

Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil.

Hammer KA, Carson CF, Riley TV.

J Appl Microbiol. 2003;95(4):853-60.

32.

Non-antibiotic therapies for infectious diseases.

Carson CF, Riley TV.

Commun Dis Intell Q Rep. 2003;27 Suppl:S143-6.

33.

In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi.

Hammer KA, Carson CF, Riley TV.

J Antimicrob Chemother. 2002 Aug;50(2):195-9.

PMID:
12161399
35.

Safety, efficacy and provenance of tea tree (Melaleuca alternifolia) oil.

Carson CF, Riley TV.

Contact Dermatitis. 2001 Aug;45(2):65-7. Review.

PMID:
11553113
36.

Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis.

Carson CF, Ashton L, Dry L, Smith DW, Riley TV.

J Antimicrob Chemother. 2001 Sep;48(3):450-1. No abstract available.

PMID:
11533019
37.
38.
39.

Melaleuca alternifolia (tea tree) oil inhibits germ tube formation by Candida albicans.

Hammer KA, Carson CF, Riley TV.

Med Mycol. 2000 Oct;38(5):355-62.

PMID:
11092382
40.

Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus.

Caelli M, Porteous J, Carson CF, Heller R, Riley TV.

J Hosp Infect. 2000 Nov;46(3):236-7.

PMID:
11073734
41.

Prevalence of delayed hypersensitivity to the European standard series in a self-selected population.

Greig JE, Carson CF, Stuckey MS, Riley TV.

Australas J Dermatol. 2000 May;41(2):86-9.

PMID:
10812700
42.
43.

Allergic contact dermatitis following use of a tea tree oil hand-wash not due to tea tree oil.

Greig JE, Thoo SL, Carson CF, Riley TV.

Contact Dermatitis. 1999 Dec;41(6):354-5. No abstract available.

PMID:
10617229
44.

Antimicrobial activity of essential oils and other plant extracts.

Hammer KA, Carson CF, Riley TV.

J Appl Microbiol. 1999 Jun;86(6):985-90.

45.
46.

In vitro susceptibilities of lactobacilli and organisms associated with bacterial vaginosis to Melaleuca alternifolia (tea tree) oil.

Hammer KA, Carson CF, Riley TV.

Antimicrob Agents Chemother. 1999 Jan;43(1):196. No abstract available.

47.
48.

Efficacy and safety of tea tree oil as a topical antimicrobial agent.

Carson CF, Riley TV, Cookson BD.

J Hosp Infect. 1998 Nov;40(3):175-8. Review. No abstract available.

PMID:
9830588
49.

In vitro susceptibility of Malassezia furfur to the essential oil of Melaleuca alternifolia.

Hammer KA, Carson CF, Riley TV.

J Med Vet Mycol. 1997 Sep-Oct;35(5):375-7.

PMID:
9402533
50.

In-vitro activity of the essential oil of Melaleuca alternifolia against Streptococcus spp.

Carson CF, Hammer KA, Riley TV.

J Antimicrob Chemother. 1996 Jun;37(6):1177-8. No abstract available.

PMID:
8836821

Supplemental Content

Loading ...
Support Center